Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 3:54 AM ET

Sponsor Check › Person

Caitlin Cameron

Named as an officer, director or promoter on SEC Form D filings · WA · Jun 18, 2010 → Feb 15, 2024

3deals (issuers)

$29.9Mreported sold

260investors

15Form D filings

2010–2024years on file

Follow this person Look further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:21 AM ET · SEC enforcement last checked: not yet

The short version

Caitlin Cameron is listed as an executive officer and director on 15 SEC Form D filings by 3 issuers between Jun 2010 and Feb 2024: OtoNexus Medical Technologies, Inc. (Bellevue, WA — other health care — 2013–2024; $19.5M reported sold to 190 investors), Presage Biosciences, Inc. (Seattle, WA — other health care — 2010–2011; $8M reported sold to 51 investors) and Precision Image Analysis, Inc. (Kirkland, WA — other health care — 2014–2015; $2.44M reported sold to 19 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 14 years. Across those companies the filings report $29.9M sold in total.

Listed alongside George A. Gates (11 shared filings), Marion R. Foote (11 shared filings), Mark A. Moehring (11 shared filings), Harris Brody (10 shared filings), Rhonda F. Rhyne (9 shared filings) and 8 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Caitlin. Each name links to their own page.

1 of the issuers belongs to the sponsor group Presage (2 issuers, $16.1M reported sold, 2010–2024).

What this means A sponsor group is one team that sets up a new company for each deal. Presage has 2 companies on file and $16.1M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), state securities regulators (AZ, CA, DE, TX, WA) — none found. Not yet searched: SEC enforcement releases.

What this means Nothing turned up where we looked (2 sources). That does not prove there is nothing — it means none was found in those sources on that date.

What the community is saying

Nothing found on Reddit, BiggerPockets or community forums for high-net-worth investors (searched Oct 24, 2026) — search queued; this line updates when it has run.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 24, 2026, 2:21 AM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

Not yet searched

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched.

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

No SEC search has run yet for this person.

3. Bankruptcies

None found in sources searched

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:21 AM ET.

4. Differences between public sources

Not made for individual people — comparisons cover issuers and sponsor groups

5. Money to insiders

0 of 10 offerings report sales commissions; 0 report finder's fees; 1 reports proceeds to related persons totalling $50,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)	Sales commissions	Finder's fees	To insiders	Paid to sell it	Source
Feb 15, 2024 D/A OtoNexus Medical Technologies, Inc. File 021-463970	$0	$0	$0	None listed on this filing	EDGAR ↗
Jan 14, 2022 D OtoNexus Medical Technologies, Inc. File 021-429580	$0	$0	$0	None listed on this filing	EDGAR ↗
Jun 4, 2021 D/A OtoNexus Medical Technologies, Inc. File 021-330341	$0	$0	$0	None listed on this filing	EDGAR ↗
Jan 12, 2017 D OtoNexus Medical Technologies, Inc. File 021-278310	$0	$0	$0	None listed on this filing	EDGAR ↗
Jun 23, 2016 D/A OtoNexus Medical Technologies, Inc. File 021-245942	$0	$0	$0	None listed on this filing	EDGAR ↗
Aug 7, 2015 D Precision Image Analysis, Inc. File 021-245321	$0	$0	$0	None listed on this filing	EDGAR ↗
Apr 24, 2014 D Precision Image Analysis, Inc. File 021-216148	$0	$0	$0	None listed on this filing	EDGAR ↗
Sep 9, 2013 D OtoNexus Medical Technologies, Inc. File 021-202504	$0	$0	$50,000 (est.)	None listed on this filing	EDGAR ↗
Aug 4, 2011 D Presage Biosciences, Inc. File 021-163934	$0	$0	$0	None listed on this filing	EDGAR ↗
Jun 18, 2010 D/A Presage Biosciences, Inc. File 021-139820	$0	$0	$0	None listed on this filing	EDGAR ↗

How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Caitlin Cameron on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Other Health Care

OtoNexus Medical Technologies, Inc.

Bellevue, WA · Sep 9, 2013 → Feb 15, 2024 · 11 filings

Feb 15, 2024 · D/A · $12,897,583 sold of $15,000,000 · 114 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Nov 4, 2022 · D · $3,498,528 sold of $10,000,000 · 31 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Jan 14, 2022 · D · $1,908,501 sold of $5,000,000 · 21 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Jun 4, 2021 · D/A · $19,501,795 sold of $28,194,000 · 190 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Mar 16, 2020 · D/A · $9,773,955 sold of $18,194,000 · 97 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Jan 11, 2019 · D · $4,406,445 sold of $8,270,000 · 44 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Jan 12, 2017 · D · $7,849,073 sold of $9,230,000 · 80 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Jun 23, 2016 · D/A · $2,158,070 sold of $2,500,000 · 54 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Nov 25, 2015 · D/A · $2,158,070 sold of $2,500,000 · 54 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Aug 17, 2015 · D · $754,990 sold of $2,000,000 · 17 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Sep 9, 2013 · D · $50,000 sold of $350,000 · 2 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗

Raised $19.5M from 190 investors (100% of the $15M target) as of the latest filing. Caitlin is listed as executive officer, director on 11 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care

Precision Image Analysis, Inc.

Kirkland, WA · Apr 24, 2014 → Aug 7, 2015 · 2 filings

Aug 7, 2015 · D · $60,348 sold of $1,500,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
Apr 24, 2014 · D · $0 sold of $1,000,000 · 0 investors · min. $50,000 · role: Director EDGAR ↗

Raised $2.44M from 19 investors (100% of the $1.5M target) as of the latest filing. Caitlin is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗

Sources

Other Health Care · group: Presage

Presage Biosciences, Inc.

Seattle, WA · Jun 18, 2010 → Aug 4, 2011 · 2 filings

Aug 4, 2011 · D · $1,566,295 sold of $10,500,000 · 20 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Jun 18, 2010 · D/A · $3,818,874 sold of $4,000,000 · 51 investors · min. $1 · role: Executive Officer, Director EDGAR ↗

Raised $8M from 51 investors (76% of the $10.5M target) as of the latest filing. Caitlin is listed as executive officer, director on 2 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Caitlin 13

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

Person

Marion R. Foote

Director · 11 shared filings (2 issuers) · also on 4 other issuers

Marion R. Foote is on 6 issuers in total — a repeat sponsor. Their page lists every one.

Person